Managing Bariatric Surgery Pathways

1. What is the patient's current BMI and highest documented BMI? Default: [VERIFY]
2. What obesity-related comorbidities are documented (T2DM, HTN, OSA, NASH, GERD, OA, etc.)? Default: [VERIFY]
3. What prior weight loss attempts have been made (diet, exercise, medications, programs)? Default: [VERIFY]
4. What insurance plan does the patient have, and what are its specific bariatric surgery requirements? Default: [VERIFY — contact insurance for policy]
5. Has the patient completed or started a supervised weight management program? Default: not yet started
6. Has psychological evaluation been completed? Default: no
7. Does the patient have a history of substance abuse? Default: no
8. What procedure is being considered (sleeve gastrectomy, Roux-en-Y gastric bypass, SADI-S, revision)? Default: to be determined after evaluation

Documents to Request

• Insurance policy bariatric surgery requirements (letter of medical necessity template)
• Prior weight loss program documentation (physician-supervised diet records)
• Psychological evaluation report
• Nutrition consultation records
• Sleep study results (if OSA suspected or documented)
• Endocrine evaluation (TSH, cortisol if clinically indicated)
• Upper GI endoscopy or UGI series (per ASMBS guidelines)
• MBSAQIP data collection forms
• Current medication list (especially diabetes, HTN, psych medications)

Step 1: Patient Eligibility Assessment

NIH/ASMBS Criteria for Bariatric Surgery

Comorbidity Documentation

Document each comorbidity with objective evidence:

Step 2: Insurance Authorization Process

Common Insurance Requirements (vary by plan)

Letter of Medical Necessity Template Components

1. Patient demographics and BMI history (highest, current, duration of obesity)
2. Complete list of obesity-related comorbidities with objective evidence
3. History of failed conservative weight loss attempts with specifics
4. Current medications required for obesity-related conditions
5. Proposed surgical procedure with rationale
6. Expected outcomes (comorbidity resolution rates specific to the proposed procedure)
7. Surgeon credentials and program MBSAQIP accreditation status
8. References to ASMBS/NIH consensus guidelines supporting surgical eligibility

Step 3: Preoperative Optimization

Medical Clearance Workup

Preoperative Targets

• A1c <8% (ideally <7%) for elective surgery
• CPAP compliance documented if OSA (≥4h/night, ≥70% of nights for 30 days)
• Smoking cessation ≥6 weeks (cotinine testing may be required)
• Alcohol cessation documented
• Weight loss of 5-10% of excess body weight (liver shrinkage diet for 2-4 weeks preop) — reduces liver volume and improves surgical access

Step 4: Procedure Selection

Comparison of Common Bariatric Procedures

Key procedure selection factors:

• GERD or Barrett's esophagus → RYGB preferred (SG may worsen)
• BMI >50 → Consider RYGB or SADI-S for greater expected weight loss
• Medication absorption concerns → SG preferred (no bypass of absorption sites)
• Prior abdominal surgery with hostile abdomen → SG preferred (simpler operation)
• T2DM as primary indication → RYGB or SADI-S (higher metabolic resolution rates)

Step 5: Postoperative Nutrition and Long-Term Follow-Up

Postoperative Diet Progression

Lifetime Supplementation (procedure-dependent)

MBSAQIP Follow-Up Schedule

Checkpoint B: Post-Draft Alignment (Mandatory)

1. Does the patient meet NIH/ASMBS eligibility criteria with documented BMI and comorbidities?
2. Is the insurance authorization complete with all required elements (supervised weight management, psych eval, nutritional eval)?
3. Is the procedure selection documented with rationale addressing patient-specific factors (GERD, BMI, T2DM)?
4. Is the preoperative optimization complete (A1c target, CPAP compliance, liver shrinkage diet)?
5. Is the postoperative nutrition and follow-up plan documented per MBSAQIP requirements?

Quality Audit

• BMI documented with height and weight (minimum 2 measurements with dates)
• Comorbidities documented with objective evidence (labs, studies, specialist notes)
• Prior weight loss attempts documented with specifics (program, duration, outcome)
• Supervised weight management visits documented (monthly, consecutive)
• Psychological evaluation completed by licensed professional
• Nutritional evaluation completed by registered dietitian
• Insurance authorization obtained with all required documentation
• Preoperative labs and studies completed (including EGD and sleep study)
• A1c within target range for elective surgery
• CPAP compliance documented (if OSA)
• Smoking and alcohol cessation documented
• Liver shrinkage diet prescribed and initiated 2-4 weeks preop
• Procedure selection documented with patient-specific rationale
• Postoperative diet progression plan provided to patient
• Lifetime supplementation regimen prescribed
• MBSAQIP follow-up schedule documented

Guidelines

1. Never proceed to surgery without complete insurance authorization — retrospective denial after a bariatric procedure creates catastrophic revenue loss and patient financial burden.
2. The supervised weight management period must be consecutive and documented monthly. A gap of >30 days between visits may reset the clock per most insurance policies.
3. EGD is strongly recommended by ASMBS for all bariatric patients and is mandatory before Roux-en-Y gastric bypass. H. pylori must be treated before surgery. Barrett's esophagus is a relative contraindication to sleeve gastrectomy.
4. Psychological evaluation must address substance abuse history, binge eating disorder, psychiatric stability, and informed understanding of the lifelong dietary and lifestyle changes required. Active untreated substance abuse or bulimia are contraindications.
5. Lifetime nutritional supplementation is non-negotiable, especially after bypass procedures. Thiamine deficiency can cause irreversible Wernicke encephalopathy, and calcium/vitamin D deficiency leads to metabolic bone disease.
6. MBSAQIP requires long-term follow-up data. Programs that lose patients to follow-up jeopardize accreditation. Document follow-up compliance rates and implement outreach for patients overdue for visits.
7. For patients with BMI 30-34.9, the 2022 ASMBS/IFSO update supports surgery for metabolic disease — but insurance coverage for this population remains inconsistent. Document the guideline citation in the letter of medical necessity.